Percutaneous vascular interventions versus intravenous thrombolytic treatment for acute ischaemic stroke.

ABSTRACT:

Background

Most ischaemic strokes are caused by blockage of a cerebral artery by a thrombus. Intravenous administration of recombinant tissue plasminogen activator given within 4.5 hours is now standard treatment for this condition. Percutaneous vascular interventions use an intra-arterial, mechanical approach for thrombus disruption or removal (thrombectomy). Recent randomised trials indicate that percutaneous vascular interventions are superior to usual care (usual care usually included intravenous thrombolysis). However, intravenous thrombolysis was usually given in both arms of the trial and there was a lack of direct comparison of percutaneous vascular interventions with intravenous thrombolysis.

Objectives

To assess the effectiveness and safety of percutaneous vascular

SUBMITTER: Lindekleiv H 

PROVIDER: S-EPMC6516947 | biostudies-literature | 2018 Oct

REPOSITORIES: biostudies-literature